A role for macrophage migration inhibitory factor in protective immunity against Aspergillus fumigatus

Immunobiology

Volumn 216, Issue 9, 2011, Pages 1018-1027

  Stojanovic, Ivana ^a   Mirkov, Ivana ^a   Kataranovski, Milena ^a   Glamoclija, Jasmina ^a   Stosic Grujicic, Stanislava ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Acquired immunity; Aspergillus fumigatus; Cytokines; Innate immunity; Macrophage migration inhibitory factor

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; MACROPHAGE MIGRATION INHIBITION FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPERGILLOSIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; FEMALE; HOST RESISTANCE; INFECTION RESISTANCE; INFECTION SENSITIVITY; MACROPHAGE MIGRATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGEN LOAD; PRIORITY JOURNAL; PROTEIN FUNCTION;

ADAPTIVE IMMUNITY; ANIMALS; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; CYTOKINES; ENZYME INHIBITORS; FEMALE; IMMUNITY, INNATE; INFLAMMATION; INTRAMOLECULAR OXIDOREDUCTASES; ISOXAZOLES; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; SIGNAL TRANSDUCTION;

EID: 79960842247     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2011.03.005     Document Type: Article

References (74)

1. Arjona A., Foellmer H.G., Town T., Leng L., McDonald C., Wang T., Wong S.J., Montgomery R.R., Fikriq E., Bucala R. Abrogation of macrophage migration inhibitory factor decreases West Nile virus lethality by limiting viral neuroinvasion. J. Clin. Invest. 2007, 117:3059-3066.
2. Assunção-Miranda I., Amaral F.A., Bozza F.A., Fagundes C.T., Sousa L.P., Souza D.G., Pacheco P., Barbosa-Lima G., Gomes R.N., Bozza P.T., Da Poian A.T., Teixeira M.M., Bozza M.T. Contribution of macrophage migration inhibitory factor to the pathogenesis of dengue virus infection. FASEB J. 2010, 24:218-228.
3. Bacher M., Metz C.N., Calandra T., Mayer K., Chesney J., Lohoff M., Gemsa D., Donnelly T., Bucala R. An essential regulatory role for macrophage migration inhibitory factor in T-cell activation. Proc. Natl. Acad. Sci. U.S.A. 1996, 93:7849-7854.
4. Bernhisel-Broadbent J., Camargo E.E., Jaffe H.S., Lederman H.M. Recombinant human interferon-gamma as adjunct therapy for Aspergillus infection in a patient with chronic granulomatous disease. J. Infect. Dis. 1991, 163:908-911.
5. Bozza S., Gaziano R., Spreca A., Bacci A., Montagnoli C., di Francesco P., Romani L. Dendritic cells transport conidia and hyphae of Aspergillus fumigatus from the airways to the draining lymph nodes and initiate disparate Th responses to the fungus. J. Immunol. 2002, 168:1362-1371.
6. Braedel S., Radsak M., Einsele H., Latgé J.P., Michan A., Loeffler J., Haddad Z., Grigoleit U., Schild H., Hebart H. Aspergillus fumigatus antigens activate innate immune cells via toll-like receptors 2 and 4. Br. J. Haematol. 2004, 125:392-399.
7. Brummer E., Stevens D.A. Collectins and fungal pathogens: roles of surfactant proteins and mannose binding lectin in host resistance. Med. Mycol. 2010, 48:16-28.
8. Calandra T. Macrophage migration inhibitory factor and host innate immune responses to microbes. Scand. J. Infect. Dis. 2003, 35:573-576.
9. Calandra T., Echtenacher B., Roy D.L., Pugin J., Metz C.N., Hultner L.H., Heumann D., Mannel D., Bucala R., Glauser M.P. Protection from septic shock by neutralization of macrophage migration inhibitory factor. Nat. Med. 2000, 6:164-170.
10. Calandra T., Roger T. Macrophage migration inhibitory factor: a regulator of innate immunity. Nat. Rev. Immunol. 2003, 3:791-800.
11. Cenci E., Mencacci A., Casagrande A., Mosci P., Bistoni F., Romani L. Impaired antifungal effector activity but not inflammatory cell recruitment in interleukin-6-deficient mice with invasive pulmonary aspergillosis. J. Infect. Dis. 2001, 184:610-617.
12. Cenci E., Mencacci A., Del Sero G., Bacci A., Montagnoli C., Fè d'Ostiani C., Mosci P., Bachmann M., Bistoni F., Kopf M., Romani L. Interleukin-4 causes susceptibility to invasive pulmonary aspergillosis through suppression of protective type I responses. Infect. Dis. 1999, 180:1957-1968.
13. Cenci E., Perito S., Enssle K.H., Mosci P., Latge J.P., Romani L., Bistoni F. Th1 and Th2 cytokines in mice with invasive aspergillosis. Infect. Immun. 1997, 65:564-570.
14. Cheng Q., McKeown S.J., Santos L., Santiago F.S., Khachigian L.M., Morand E.F., Hickey M.J. Macrophage migration inhibitory factor increases leukocyte-endothelial interactions in human endothelial cells via promotion of expression of adhesion molecules. J. Immunol. 2010, 185:1238-1247.
15. Clemons K.V., Grunig G., Sobel R.A., Mirels L.F., Rennick D.M., Stevens D.A. Role of IL-10 in invasive aspergillosis: increased resistance of IL-10 gene knockout mice to lethal systemic aspergillosis. Clin. Exp. Immunol. 2000, 122:186-191.
16. Clemons K.V., Martinez M., Tong A.J., Stevens D.A. Resistance of MBL gene-knockout mice to experimental systemic aspergillosis. Immunol. Lett. 2010, 128:105-107.
17. Clemons K.V., Stevens D.A. The contribution of animal models of aspergillosis to understanding pathogenesis, therapy and virulence. Med. Mycol. 2005, 43:S101-S110.
18. Curtis M.M., Way S.S. Interleukin-17 in host defense against bacterial, mycobacterial and fungal pathogens. Immunology 2009, 126:177-185.
19. Cvetkovic I., Al-Abed Y., Miljkovic D., Maksimovic-Ivanic D., Roth J., Bacher M., Lan H.Y., Nicoletti F., Stosic-Grujicic S. Critical role of macrophage migration inhibitory factor activity in experimental autoimmune diabetes. Endocrinology 2005, 146:2942-2951.
20. Cvetkovic I., Stosic-Grujicic S. Neutralization of macrophage migration inhibitory factor - novel approach for the treatment of immunoinflammatory disorders. Int. Immunopharmacol. 2006, 6:1527-1534.
21. de Jong Y.P., Abadia-Molina A.C., Satoskar A.R., Clarke K., Faubion W.A. Development of chronic colitis is dependent on the cytokine MIF. Nat. Immunol. 2001, 2:1061-1066.
22. de Repentigny L., Petitbois S., Boushira M., Michaliszyn E., Sénéchal S., Gendron N., Montplaisir S. Acquired immunity in experimental murine aspergillosis is mediated by macrophages. Infect. Immun. 1993, 61:3791-3802.
23. Defaveri J., Rezkallah-Iwasso M.T., Franco M.F. Pulmonary paracoccidioidomycosis in immunized mice. Mycopathologia 1992, 119:1-9.
24. Duong M., Ouellet N., Simard M., Bergeron Y., Olivier M., Bergeron M.G. Kinetic study of host defense and inflammatory response to Aspergillus fumigatus in steroid-induced immunosuppressed mice. J. Infect. Dis. 1998, 178:1472-1482.
25. Farah C.S., Hong S., Wanasaengsakul S., Elahi S., Pang G., Gotjamanos T., Seymour G.J., Clancy R.L., Ashaman R.B. Irradiation-induced oral candidiasis in an experimental murine model. Oral Microbiol. Immunol. 2001, 16:358-363.
26. Fingerle-Rowson G., Petrenko O., Metz C.N., Forsthuber T.G., Mitchell R., Huss R., Moll U., Muller W., Bucala R. The p53-dependent effects of macrophage migration inhibitory factor revealed by gene targeting. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:9354-9359.
27. Flores M., Saavedra R., Bautista R., Viedma R., Tenorio E.P., Leng L., Sanchez Y., Juarez I., Satoskar A.A., Shenoy A.S., Terrazas L.I., Bucala R., Barbi J., Satoskar A.R., Rodriquez-Sosa M. Macrophage migration inhibitory factor (MIF) is critical for the host resistance against Toxoplasma gondii. FASEB J. 2008, 22:3661-3671.
28. Golec M., Skórska C., Mackiewicz B., Dutkiewicz J. Immunologic reactivity to work-related airborne allergens in people occupationally exposed to dust from herbs. Ann. Agric. Environ. Med. 2004, 11:121-127.
29. Graybill J.R., Ahrens J., Nealon T., Paque R. Pulmonary cryptococcosis in the rat. Am. Rev. Respir. Dis. 1983, 127:636-640.
30. Koebernick H., Grode L., David J.R., Rohde W., Rolph M.S., Mittrücker H.W., Kaufmann S.H.E. Macrophage migration inhibitory factor (MIF) plays a pivotal role in immunity against Salmonella typhimurium. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:13681-13686.
31. Krysińska-Traczyk E., Dutkiewicz J. Aspergillus candidus: a respiratory hazard associated with grain dust. Ann. Agric. Environ. Med. 2000, 7:101-109.
32. LeibundGut-Landmann S., Gross O., Robinson M.J., Osorio F., Slack E.C., Tsoni S.V., Schwieghoffer E., Tybulewicz V., Brown G.D., Ruland J., Reis e Sousa C. Syk- and Card9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17. Nat. Immunol. 2007, 8:630-638.
33. Lue H., Kleemann R., Calandra T., Roger T., Bernhagen J. Macrophage migration inhibitory factor (MIF): mechanisms of action and role in disease. Microbes Infect. 2002, 4:449-460.
34. Magill S.S., Chiller T.M., Warnock D.W. Evolving strategies in the management of aspergillosis. Expert Opin. Pharmacother. 2008, 9:193-209.
35. Marr K.A., Patterson T., Denning D. Aspergillosis. Pathogenesis, clinical manifestations, and therapy. Infect. Dis. Clin. North Am. 2002, 16:875-894.
36. Martiney J.A., Sherry B., Metz C.N., Espinoza M., Ferrer A.S., Calandra T., Broxmeyer H.E., Bucala R. Macrophage migration inhibitory factor release by macrophages after ingestion of Plasmodium chabaudi-infected erythrocytes: possible role in the pathogenesis of malarial anemia. Infect. Immun. 2000, 68:2259-2267.
37. Matsuzaki G., Umemura M. Interleukin-17 as an effector molecule of innate and acquired immunity against infections. Microbiol. Immunol. 2007, 51:1139-1147.
38. Mebius R.E., Kraal G. Structure and function of the spleen. Nat. Rev. Immunol. 2005, 5:606-616.
39. Mehrad B., Strieter R.M., Standiford T.J. Role of TNF-α in pulmonary host defense in murine invasive aspergillosis. J. Immunol. 1999, 162:1633-1640.
40. Meier A., Kirschning C.J., Nikolaus T., Wagner H., Heesemann J., Ebel F. Toll-like receptor (TLR) 2 and TLR4 are essential for Aspergillus-induced activation of murine macrophages. Cell. Microbiol. 2003, 5:561-570.
41. Mirkov I., Stojanovic I., Glamoclija J., Stosic-Grujicic S., Zolotarevski L., Kataranovski D., Kataranovski M. Differential mechanisms of resistance to sublethal systemic Aspergillus fumigatus infection in immunocompetent BALB/c and C57BL/6 mice. Immunobiology 2011, 216:234-242.
42. Mirkov I., Stojanovic I., Stosic-Grujicic S., Glamoclija J., Zolotarevski L., Kataranovski D., Kataranovski M. Splenic and lung response to nonlethal systemic Aspergillus fumigatus infection in C57BL/6 mice. Med. Mycol. 2010, 48:735-743.
43. Mirkov I., Zolotarevski L., Glamoclija J., Kataranovski D., Kataranovski M. Experimental disseminated aspergillosis in mice: histopathological study. J. Mycol. Med. 2008, 18:75-82.
44. Morgan J., Wannemuehler K.A., Marr K.A., Hadley S., Kontoyiannis D.P., Walsh T.J., Fridkin S.K., Pappas P.G., Warnock D.W. Incidence of invasive aspergillosis following hematopoietic stem cell and solid organ transplantation: interim results of a prospective multicenter surveillance program. Med. Mycol. 2005, 43:S49-S58.
45. Netea M.G., Ferwerda G., van der Graaf C.A., van der Meer J.W., Kullberg B.J. Recognition of fungal pathogens by Toll-like receptors. Curr. Pharm. Des. 2006, 12:4195-4201.
46. Netea M.G., Warris A., Van der Meer J.W., Fenton M.J., Verver-Janssen T.J., Jacobs L.E., Andersen T., Verweij P.E., Kullberg B.J. Aspergillus fumigatus evades immune recognition during germination through loss of toll-like receptor-4-mediated signal transduction. J. Infect. Dis. 2003, 188:320-326.
47. Nicolo C., Le Roy D., Reymond M.K., Roger T., Calandra T. Macrophage migration inhibitory factor plays an important role in the host innate immune defenses against Candida infection. Int. J. Infect. Dis. 2006, 10:S46-47.
48. Rex J.H., Bennett J.E., Gallin J.I., Malech H.L., DeCarlo E.S., Melnick D.A. In vivo interferon-γ therapy augments the in vitro ability of chronic granulomatous disease neutrophils to damage Aspergillus hyphae. J. Infect. Dis. 1991, 163:849-852.
49. +-T-cell responses to live and heat-inactivated Aspergillus fumigatus conidia. Infect. Immun. 2005, 73:7170-7179.
50. Rødland E.K., Ager-Wick E., Halvorsen B., Müller F., Frøland S.S. Toll like receptor 5 (TLR5) may be involved in the immunological response to Aspergillus fumigatus in vitro. Med. Mycol. 2010, 10.3109/13693786.2010.531772.
51. Rodriguez-Sosa M., Rosas L.E., David J.R., Bojalil R., Satoskar A.R., Terrazas L.I. Macrophage migration inhibitory factor plays a critical role in mediating protection against the helminth parasite Taenia crassiceps. Infect. Immun. 2003, 71:1247-1254.
52. Roger T., David J., Glauser M.P., Calandra T. MIF regulates innate immune responses through modulation of Toll-like receptor 4. Nature 2001, 414:920-924.
53. Roilides E., Dimitriadou-Georgiadou A., Sein T., Kadiltsoglou I., Walsh T.J. Tumor necrosis factor-α enhances anti-fungal activities of polymorphonuclear and mononuclear phagocytes against Aspergillus fumigatus. Infect. Immun. 1998, 66:5999-6003.
54. Roilides E., Uhlig K., Venzon D., Pizzo P.A., Walsh T.J. Enhancement of oxidative response and damage caused by human neutrophils to Aspergillus fumigatus hyphae by granulocyte colony-stimulating factor and gamma interferon. Infect. Immun. 1993, 61:1185-1193.
55. Romani L. Immunity to fungal infections. Nat. Rev. Immunol. 2004, 4:1-23.
56. Romani L. Cell mediated immunity to fungi: a reassessment. Med. Mycol. 2008, 46:515-529.
57. Sashinami H., Sakuraba H., Ishiguro Y., Munakata A., Nishihira J., Nakane A. The role of macrophage migration inhibitory factor in lethal Listeria monocytogenes infection in mice. Microb. Pathog. 2006, 41:111-118.
58. Schaffner A., Douglas H., Braude A. Selective protection against conidia by mononuclear and against mycelia by polymorphonuclear phagocytes in resistance to Aspergillus: observations on these two lines of defense in vivo and in vitro with human and mouse phagocytes. J. Clin. Invest. 1982, 69:617-631.
59. Singh S., Kochhar R., Dutta U. Severe duodenal candidiasis in a patient with IgA deficiency and T cell defects. Indian J. Gastroenterol. 1990, 9:95-96.
60. Stojanović I., Cvjetićanin T., Lazaroski S., Stošić-Grujičić S., Miljković D. Macrophage migration inhibitory factor stimulates interleukin-17 expression and production in lymph node cells. Immunology 2009, 126:74-83.
61. Sugui J.A., Kim H.S., Zarember K.A., Chang Y.C., Gallin J.I., Nierman W.C., Kwon-Chung K.J. Genes differentially expressed in conidia and hyphae of Aspergillus fumigatus upon exposure to human neutrophils. PLoS One 2008, 3:e2655. 10.1371/journal.pone.0002655.
62. Suzuki T., Ogata A., Tashiro K., Nagashima K., Tamura M., Yasui K., Nishihira J. Japanese encephalitis virus up-regulates expression of macrophage migration inhibitory factor (MIF) mRNA in the mouse brain. Biochim. Biophys. Acta 2000, 1517:100-106.
63. Tanuma H., Asai T., Abe M., Nishiyama S., Katsuoka K. Case report. Lymphatic vessel-type sporotrichosis: immunohistochemical evaluation and cytokine expression pattern. Mycoses 2001, 44:316-320.
64. Taramelli D., Malabarba M.G., Sala N., Basilico G., Cocuzza G. Production of cytokines by alveolar and peritoneal macrophages stimulated by Aspergillus fumigatus conidia or hyphae. J. Med. Vet. Mycol. 1996, 34:49-56.
65. Tewari R.P., Von Behren L.A. Immune responses in histoplasmosis, a prototype of respiratory mycoses. Indian J. Chest Dis. Allied Sci. 2000, 42:265-269.
66. Vorob′ev K.V., Gankovskaya L.V., Koval′chuk L.V., Shabanova L.F. Interlinear differences in mice in production of migration inhibition factor to Candida albicans antigens. Bull. Exp. Biol. Med. 1983, 96:1437-1439.
67. Wang J.E., Warris A., Ellingsen E.A., Jorgensen P.F., Flo T.H., Espevik T., Solberg R., Verweij P.E., Aasen A.O. Involvement of CD14 and Toll-like receptors in activation of human monocytes by Aspergillus fumigatus hyphae. Infect. Immun. 2001, 69:2402-2406.
68. Warris A., Netea M.G., Verweij P.E., Gaustad P., Kullberg B.J., Weemaes C.M., Abrahamsen T.G. Cytokine responses and regulation of interferon-gamma release by human mononuclear cells to Aspergillus fumigatus and other filamentous fungi. Med. Mycol. 2005, 43:613-621.
69. Weiser W.Y., Pozzi L.M., David J.R. Human recombinant migration inhibitory factor activates human macrophages to kill Leishmania donovani. J. Immunol. 1991, 147:2006-2011.
70. Werner J.L., Metz A.E., Horn D., Schoeb T.R., Hewitt M.M., Schwiebert L.M., Faro-Trindade I., Brown G.D., Steele C. Requisite role for the dectin-1 beta-glucan receptor in pulmonary defense against Aspergillus fumigatus. J. Immunol. 2009, 182:4938-4946.
71. Wong B.L., Zhu S.L., Huang X.R., Ma J., Xia H.H., Bucala R., Wong B.C., Lan H.Y. Essential role for macrophage migration inhibitory factor in gastritis induced by Helicobacter pylori. Am. J. Pathol. 2009, 174:1319-1328.
72. Zaas A.K., Liao G., Chien J.W., Weinberg C., Shore D., Giles S.S., Marr K., Usuka A.J., Burch L.H., Perera L., Perfect J.R., Peltz G., Schwartz D.A. Plasminogen alleles influence susceptibility to invasive aspergillosis. PLoS Genet. 2008, 4:e1000101.
73. Zelante T., De Luca A., Bonifazi T., Montagnoli C., Bozza S., Moretti S., Belladonna M.L., Vacca C., Conte C., Mosci P., Bistoni F., Puccetti P., Kastelein R.A., Kopf M., Romani L. IL-23 and the Th17 pathway promote inflammation and impair antifungal immune resistance. Eur. J. Immunol. 2007, 37:2695-2706.
74. Zelante T., De Luca A., D'Angelo C., Moretti S., Romani L. IL-17/Th17 in anti-fungal immunity: what's new?. Eur. J. Immunol. 2009, 39:645-648.